2BB score and signals
Bicara Therapeutics Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 22 | Weak |
| Quality | 100 | Very Strong |
| Risk | 15 | Very Low |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2018 |
| Employees | 103 |
| 52-week range | $8.74 – $29.90 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.8703 | — | $0.00 |
| 2026-08-11 | — | -0.8469 | — | $0.00 |
| 2026-05-11 | -0.93 | -0.6644 | $0.00 | $0.00 |
| 2026-03-26 | — | -0.6845 | — | $0.00 |
2BBBullish & Bearish